The global cannula market size was estimated to be USD 180.52 million in 2023 and is expected to reach at USD 403.25 million by 2033 with a CAGR of 7.58% during the forecast period 2024-2034. Surge in demand for minimally invasive surgeries, rising prevalence of chronic diseases such as diabetes & cardiovascular diseases, growing number of surgeries among the geriatric population, increasing government initiatives to provide primary healthcare services at affordable rates, surge in awareness regarding chronic diseases, rising demand for nasal cannula, growing prevalence of respiratory diseases, and increasing regulatory approvals of advanced cannula systems are some of the key factors boosting the market growth.
Increasing regulatory approvals of advanced cannula systems is predicted to boost the market growth during the forecast period. Market participants are concentrating on the development of minimally invasive surgical technologies and are anticipating FDA approvals. For instance, in January 2023, Inspira Technologies has received a patent from the U.S. Patent and Trademark Office (USPTO) for its INSPIRA™ ART System, a versatile dual lumen cannula that can be converted.
By product, cardiac was the highest revenue-grossing segment in the global cannula market in 2023 owing to the surge in prevalence of cardiovascular diseases, rising adoption of sedentary lifestyle, growing geriatric population who are more susceptible to these diseases, and increasing technological advancements in cardiac cannula devices. For instance, in July 2022, Haag-Streit U.K. has introduced the PolyVent cannula series by MedOne, offering a choice of 23g and 25g sizes along with both fixed and extendable/retractable tip options. The retractable feature enables easy insertion through valved cannulas and utilizes slim-walled, low-dead-space infusion tubing, effectively reducing injection wastage and enhancing cost-efficiency. Additionally, dermatology is predicted to grow at fastest CAGR during the forecast period owing to the rising usage of microcannulas to prevent difficulties during and after operations, surge in the number of cosmetic surgeries, and greater MIS penetration.
By type, straight was the highest revenue-grossing segment in the global cannula market in 2023 owing to its simpler-to-use design, increasing adoption in cardiac surgeries to prevent mistakes & reduce any unnecessary pauses that might lengthen the procedure, and growing initiatives by major market players. For instance, in January 2023, Sterimedix showcased its progress in international markets by introducing new cannulas for aesthetic and ophthalmic purposes during the Arab Health event. Additionally, neonatal is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of respiratory disorders among neonates and rising usage in high flow oxygen therapy for newborns.
By material, plastic was the highest revenue-grossing segment in the global cannula market in 2023 owing to its rising adoption in both in-patient & out-patient procedures, increasing demand for translucent plastic cannulas which allow surgeons to visualize instrumentation & sutures passing through the cannula in shoulder arthroscopy, and growing regulatory approval of new products. For instance, in May 2022, The U.S. Food and Drug Administration (FDA) has granted 510(k) approval to Access Vascular Inc. for their HydroPICC Dual-Lumen catheter. Additionally, Silicone is predicted to grow at fastest CAGR during the forecast period owing to the growing usage of silicone cannulas in oxygen therapies for people suffering from respiratory disorders and surge in demand among healthcare professionals & patients for silicone cannulas due to soft & flexible nature.
By size, 18G was the highest revenue-grossing segment in the global cannula market in 2023 owing to the rising adoption of 18G size cannula in hospitals for adults & adolescents, increasing usage in infuse blood products & deliver medications, surge in demand for quick blood transfusion procedures, and growing introduction of innovative products. For instance, in July 2022, B. Braun Medical Inc. has introduced the Introcan Safety 2 IV Catheter, featuring one-time blood control. This new product is designed to enhance the safety of IV access for healthcare professionals by minimizing the chances of needlestick injuries and exposure to blood. Additionally, 22G is predicted to grow at fastest CAGR during the forecast period owing to its narrow-gauge size, which enables a quicker fluid flow in patients with difficult veins and growing demand for minimally invasive procedures.
By end-user, hospitals was the highest revenue-grossing segment in the global cannula market in 2023 owing to the surge in hospital admissions due to a range of conditions & therapies and increasing mergers & acquisitions within market players. For instance, in February 2022, Gilde Healthcare, an investment firm specializing in healthcare technologies, has acquired EUROPIN, a prominent medical needle manufacturer. This acquisition aims to create a top-tier integrated contract manufacturing company focused on customized cannulas and cannula systems. Additionally, ambulatory surgical centers is predicted to grow at fastest CAGR during the forecast period owing to the provision of same-day surgical treatment in contemporary healthcare settings, together with diagnostic & preventative procedures, surge in shift towards ambulatory surgical centers to undergo treatment & avoid hospitalization.
North America region is anticipated for the highest revenue share during the forecast period owing to the accessibility to cutting-edge medical facilities, growing prevalence of lifestyle diseases, rising awareness regarding minimally invasive surgeries, surge in number of cosmetic surgeries, increasing introduction of novel products, and growing collaborations within market players. For instance, collaborations within market players. For instance, in May 2022, B. Braun Medical Inc partnered with Massachusetts General Hospital (MGH), a renowned research hospital in the United States, to collaborate on creating inventive solutions aimed at assisting frontline healthcare professionals in enhancing patient care. Together, they are also working on devising more efficient and productive care delivery models. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing geriatric population, growing burden of chronic diseases such as cardiovascular diseases & diabetes, and rising mergers & acquisitions within market players. For instance, in April 2023, Boston Scientific Corporation has revealed its plan to purchase Shockwave Medical, a company specializing in interventional cardiovascular procedures. This acquisition aligns with Boston Scientific's strategy to broaden its portfolio of cardiovascular devices, as Shockwave Medical, headquartered in California, is a prominent medical device manufacturer in this field.
Increasing regulatory approvals of advanced cannula systems is predicted to boost the market growth during the forecast period. Market participants are concentrating on the development of minimally invasive surgical technologies and are anticipating FDA approvals. For instance, in January 2023, Inspira Technologies has received a patent from the U.S. Patent and Trademark Office (USPTO) for its INSPIRA™ ART System, a versatile dual lumen cannula that can be converted.
By product, cardiac was the highest revenue-grossing segment in the global cannula market in 2023 owing to the surge in prevalence of cardiovascular diseases, rising adoption of sedentary lifestyle, growing geriatric population who are more susceptible to these diseases, and increasing technological advancements in cardiac cannula devices. For instance, in July 2022, Haag-Streit U.K. has introduced the PolyVent cannula series by MedOne, offering a choice of 23g and 25g sizes along with both fixed and extendable/retractable tip options. The retractable feature enables easy insertion through valved cannulas and utilizes slim-walled, low-dead-space infusion tubing, effectively reducing injection wastage and enhancing cost-efficiency. Additionally, dermatology is predicted to grow at fastest CAGR during the forecast period owing to the rising usage of microcannulas to prevent difficulties during and after operations, surge in the number of cosmetic surgeries, and greater MIS penetration.
By type, straight was the highest revenue-grossing segment in the global cannula market in 2023 owing to its simpler-to-use design, increasing adoption in cardiac surgeries to prevent mistakes & reduce any unnecessary pauses that might lengthen the procedure, and growing initiatives by major market players. For instance, in January 2023, Sterimedix showcased its progress in international markets by introducing new cannulas for aesthetic and ophthalmic purposes during the Arab Health event. Additionally, neonatal is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of respiratory disorders among neonates and rising usage in high flow oxygen therapy for newborns.
By material, plastic was the highest revenue-grossing segment in the global cannula market in 2023 owing to its rising adoption in both in-patient & out-patient procedures, increasing demand for translucent plastic cannulas which allow surgeons to visualize instrumentation & sutures passing through the cannula in shoulder arthroscopy, and growing regulatory approval of new products. For instance, in May 2022, The U.S. Food and Drug Administration (FDA) has granted 510(k) approval to Access Vascular Inc. for their HydroPICC Dual-Lumen catheter. Additionally, Silicone is predicted to grow at fastest CAGR during the forecast period owing to the growing usage of silicone cannulas in oxygen therapies for people suffering from respiratory disorders and surge in demand among healthcare professionals & patients for silicone cannulas due to soft & flexible nature.
By size, 18G was the highest revenue-grossing segment in the global cannula market in 2023 owing to the rising adoption of 18G size cannula in hospitals for adults & adolescents, increasing usage in infuse blood products & deliver medications, surge in demand for quick blood transfusion procedures, and growing introduction of innovative products. For instance, in July 2022, B. Braun Medical Inc. has introduced the Introcan Safety 2 IV Catheter, featuring one-time blood control. This new product is designed to enhance the safety of IV access for healthcare professionals by minimizing the chances of needlestick injuries and exposure to blood. Additionally, 22G is predicted to grow at fastest CAGR during the forecast period owing to its narrow-gauge size, which enables a quicker fluid flow in patients with difficult veins and growing demand for minimally invasive procedures.
By end-user, hospitals was the highest revenue-grossing segment in the global cannula market in 2023 owing to the surge in hospital admissions due to a range of conditions & therapies and increasing mergers & acquisitions within market players. For instance, in February 2022, Gilde Healthcare, an investment firm specializing in healthcare technologies, has acquired EUROPIN, a prominent medical needle manufacturer. This acquisition aims to create a top-tier integrated contract manufacturing company focused on customized cannulas and cannula systems. Additionally, ambulatory surgical centers is predicted to grow at fastest CAGR during the forecast period owing to the provision of same-day surgical treatment in contemporary healthcare settings, together with diagnostic & preventative procedures, surge in shift towards ambulatory surgical centers to undergo treatment & avoid hospitalization.
North America region is anticipated for the highest revenue share during the forecast period owing to the accessibility to cutting-edge medical facilities, growing prevalence of lifestyle diseases, rising awareness regarding minimally invasive surgeries, surge in number of cosmetic surgeries, increasing introduction of novel products, and growing collaborations within market players. For instance, collaborations within market players. For instance, in May 2022, B. Braun Medical Inc partnered with Massachusetts General Hospital (MGH), a renowned research hospital in the United States, to collaborate on creating inventive solutions aimed at assisting frontline healthcare professionals in enhancing patient care. Together, they are also working on devising more efficient and productive care delivery models. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing geriatric population, growing burden of chronic diseases such as cardiovascular diseases & diabetes, and rising mergers & acquisitions within market players. For instance, in April 2023, Boston Scientific Corporation has revealed its plan to purchase Shockwave Medical, a company specializing in interventional cardiovascular procedures. This acquisition aligns with Boston Scientific's strategy to broaden its portfolio of cardiovascular devices, as Shockwave Medical, headquartered in California, is a prominent medical device manufacturer in this field.
Segmentation: Cannula Market Report 2022 - 2033
Cannula Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Mn)
- Nasal
- Dermatology
- Cardiac
- Arterial
- Venous
- Cardioplegia
- Others
Cannula Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Mn)
- Straight
- Neonatal
- Winged
- Winged With Stop Cork Cannulae
- A Wing With Port
Cannula Market Analysis & Forecast by Material 2023 - 2034 (Revenue USD Mn)
- Metal
- Silicone
- Plastic
Cannula Market Analysis & Forecast by Size 2023 - 2034 (Revenue USD Mn)
- 14G
- 16G
- 18G
- 20G
- 22G
- 24G
- 26G
Cannula Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Hospitals
- Ambulatory Surgical Centers
- Others
Cannula Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Cannula Market: Product Estimates & Trend Analysis
8. Cannula Market: Type Estimates & Trend Analysis
9. Cannula Market: Material Estimates & Trend Analysis
10. Cannula Market: Size Estimates & Trend Analysis
11. Cannula Market: End-user Estimates & Trend Analysis
12. Regional Market Analysis
13. North America Cannula Market
14. Europe Global Cannula Market
15. Asia Pacific Global Cannula Market
16. Latin America Global Cannula Market
17. MEA Global Cannula Market
18. Competitor Analysis
19. Company Profiles
Companies Mentioned
- McKesson Medical-Surgical Inc.
- Becton
- Dickinson and Company
- LivaNova PLC
- Teleflex Incorporated
- Denex International
- Boston Scientific Corporation
- Terumo Cardiovascular System Corporation
- Smiths Medical
- Gilde Healthcare
- Smith & Nephew
- Baihe Medical
- CONMED Corporation
- Medtronic
- ISPG Inc.
- Edwards Life sciences Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 180.52 Million |
| Forecasted Market Value ( USD | $ 403.25 Million |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
